+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Correcting biliary phenotype in cystic fibrosis mice Nor-ursodeoxycholic acid , but not UDCA, normalizes hepatic bile pH and increases bile flow in G551D CF mice



Correcting biliary phenotype in cystic fibrosis mice Nor-ursodeoxycholic acid , but not UDCA, normalizes hepatic bile pH and increases bile flow in G551D CF mice



Hepatology 36(4 Part 2): 337A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034653299

Download citation: RISBibTeXText


Related references

Treatment with ursodeoxycholic acid, but not with cholic acid, increases bile flow independently of cystic fibrosis transmembrane regulator in mice. 2007

Effect of ursodeoxycholic acid udca on hepatic bile acid handling in primary biliary cirrhosis pbc. Clinical Science 82(3): 24P-25P, 1992

Ursodeoxycholic acid udca enhances canalicular bile flow in man as measured by biliary clearance of peg 900. Gastroenterology 100(5 PART 2): A742, 1991

Effect of ursodeoxycholic acid udca treatment on the biliary secretion of bile acids and bile lipids in primary sclerosing cholangitis psc. Gastroenterology 98(5 PART 2): A637, 1990

Effect of ursodeoxycholic acid udca on hepatic bile acid synthesis in patients with external biliary drainage. Gastroenterology 102(4 PART 2): A877, 1992

Ursodeoxycholic acid udca improves hepatic bile acid transit and excretion in primary biliary cirrhosis pbc. Gastroenterology 100(5 PART 2): A756, 1991

Modulation of bile flow and of biliary bile acid and cholesterol excretion by hepatic low density lipoprotein uptake and by chenodeoxycholic acid and ursodeoxycholic acid treatment in the hamster. Gastroenterology 90(5 PART 2): 1744, 1986

Ursodeoxycholic Acid (UDCA) Therapy of Gallstones. is Correction of Biliary Cholesterol Saturation Index According to Percentage UDCA in Bile Necessary for Prediction of Gallstone Dissolution?. Clinical Science 57(3): 26p.3-27p, 1979

The effect of ursodeoxycholic acid udca on liver function and bile acid metabolism in patients with cystic fibrosis cf and liver disease. Hepatology 10(4): 726, 1989

Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration. Hepatology 12(2): 322-334, 1990

Hepatic and renal ABC transporter expression as critical determinants of ursodeoxycholic acid-induced bile infarcts in bile duct-ligated mice. Hepatology 38(4 Suppl 1): 688A-689A, 2003

Changes induced by ursodeoxycholic acid udca administration on biliary and serum bile acid composition in patients with primary biliary cirrhosis pbc. Hepatology 12(4 PART 2): 995, 1990

Ursodeoxycholate modulates bile flow and bile salt pool independently from the cystic fibrosis transmembrane regulator (Cftr) in mice. American Journal of Physiology. Gastrointestinal and Liver Physiology 302(9): G1035-G1042, 2012

Influence of ursodeoxycholic acid udca on bile acid metabolism of patients with primary biliary cirrhosis pbc. Gastroenterology 98(5 PART 2): A590, 1990

Serum bile acid levels and distribution in primary biliary cirrhosis pbc effect of ursodeoxycholic acid udca therapy. Gastroenterology 100(5 PART 2): A786, 1991